Recruiting

Observational Study

Sponsor:

Sir Mortimer B. Davis - Jewish General Hospital

Code:

NCT02355171

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The 'Personalize My treatment' (PMT) platform is a novel form of biobanking in which cancer patients willingly consent to provide residual, clinical samples (surplus after diagnostic testing) of their tumors for cancer research, to give access to their medical record for data collection and then followed prospectively throughout the trajectory of their illness. They further willingly consent to be recontacted for being informed of other research projects, including clinical trials.

Conditions

Cancer

Study ID

NCT02355171

Start date

Nov, 2015

Status verified date

Nov, 2026

Completion date

Dec, 2030

Anticipated

Primary completion date

Dec, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Age of majority in the province of recruitment.

Study Design

Enrollment

20000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • The primary objective of PMT is to create a collection of cancer patient biospecimens and annotated data that will be used for clinical trial matching and to advance cancer research. [ Time Frame: Longitudinal ]

Central Contacts and Locations

Locations

Jewish General Hospital University Health Centre

Recruiting

Montreal, Quebec, Canada, H3T 1E2

Contacts

Principal Investigator:

Mark Basik, MD

More Information

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital

Last update posted

Nov 5, 2026

Last verified

Nov, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-06. This information was provided to ClinicalTrials.gov by Sir Mortimer B. Davis - Jewish General Hospital on 2026-11-05. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.